400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
ChiCTR-TRC-11001655
结束
/
/
/
2011-11-04
/
/
Carpal Tunnel Syndrome
Electroacupuncture and Wrist Splinting for Carpal Tunnel Syndrome: A Randomized Trial in Primary Care Setting
Electroacupuncture and Wrist Splinting for Carpal Tunnel Syndrome: A Randomized Trial in Primary Care Setting
N
随机平行对照
Ⅲ期
Randomized
单盲
Health and Health Service Research Fund (HHSRF)
/
182
/
2012-04-01
1990-01-01
/
Patients aged 18-70 and fulfilling the Katz CTS hand diagram criteria of (1) Classic / Probable Symptoms or (2) Possible Symptoms. Eligible patients should also (3) have the ability to read and speak Chinese (Cantonese), and (4) agree to sign the Informed consent and (5) are willing to attend follow up and / or electroacupuncture sessions.;
请登录查看Patients with symptoms and signs of axonal loss and evident median nerve denervation, including (1) constant numbness, (2) loss of sensibility, and (3) thenar muscular atrophy or weakness will be excluded. Patients with secondary CTS caused by inflammatory arthropathy, coexisting cervical radical radiculopathy, polyneuropathy, diabetes mellitus, pregnancy, malignancy, hypothyroidism, alcoholism, rheumatoid arthritis, space-occupying lesions (tumours, hypertrophic synovial tissue, fracture callus, and osteophytes), infections, and familial neuropathy will also be excluded. In particular, cervical radiculopathy will be actively ruled out by assessing the existence of related symptoms and signs, including neck pain, reduced reflexes, less well demarcated dermatomal involvement, and positive Spurling's test. Patients who received previous carpal tunnel release surgery, or have used warfarin, oral steroid, local steroid injection, night splint or acupuncture for CTS in the past 6 months, or other serious illnesses will be considered as ineligible.;
请登录查看JC School of Public Health and Primary Care, The Chinese University of Hong Kong
/
AI 西宝生物2026-06-04
天勤生物Topgene2026-06-04
生物技术小编2026-06-04
杏泽资本2026-06-04
医药笔记2026-06-04
医药笔记2026-06-04
药明康德2026-06-04
医麦客2026-06-04
生物制品圈2026-06-03
ADC InsightsOnline2026-06-03